iShares Neuroscience and Healthcare ETF IBRN
34.79 USD -0.30 (-0.86%)
At closeNov 10, 2026, 4:15 PM EST
34.79 0.00 0.00%
After hours · Nov 10, 4:15 PM ET
34.25 Day range 34.80
28.13 52-week range 40.67
- YTD
- +7.64%
- 1 year
- +23.67%
News
zacks.com FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
benzinga.com PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity' PTC Therapeutics plans to acquire Sangamo’s ST-920 Fabry disease program for $111 million upfront, with FDA filing expected in Q4 2026.
benzinga.com Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.
benzinga.com Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves expected to reach $489 million.
etftrends.com These 10 ETFs Were Last Week's Top Performers: Oct 3, 2022 These were the best-performing ETFs for the week ending Sept. 30, 2022. NOTE: We've excluded funds that use leverage or make inverse bets on their underlying assets.
zacks.com 4 Best ETF Areas of Last Week That Are Up At Least 5% Wall Street was downbeat last week led by Apple after it dropped plans to boost production of its new iPhones.
seekingalpha.com Why Now Could Be The Time To Consider Neuroscience Investments Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in…